A qualitative exploration of the prescribing and use of statins in asymptomatic people in Ireland
A case of medicalisation, biomedicalisation and pharmaceuticalisation
Bibliographic Data
| ID | 4218482 |
|---|---|
| Authors | Paula Byrne (0000-0002-9034-5154, Ollscoil na Gaillimhe – University of Galway, corresponding author), Órla O’donovan (0000-0002-0236-3898, University College Cork), Susan M Smith (0000-0001-6027-2727, Royal College of Surgeons in Ireland), John Cullinan (0000-0003-3509-0635, Ollscoil na Gaillimhe – University of Galway) |
| Year | 2021 |
| Volume | 25 |
| Issue | 5 |
| Pages | 630-648 |
| Publication date | 2021-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine (JOURNAL) |
| Journal identifiers | ISSN: 1363-4593 • E-ISSN: 1461-7196 |
| Publisher | SAGE Publications Inc (PUBLISHER) |
| DOI | 10.1177/1363459320946067 |
| PMID | 32715773 |
| OpenAlex | W3045922630 |
| Language | EN |
| Citations received | 2 |
| References cited | 58 |
There has been a notable increase in the use of statins in people without cardiovascular disease but who may be at risk in the future. The majority of statin users now fall into this category but little research has focused exclusively on this group. Debate has ensued regarding medicating asymptomatic people, and processes described variously as medicalisation, biomedicalisation and pharmaceuticalisation are used to explain how this happens. These overlapping and interrelated processes require issues to be 'problemised' as medical problems requiring medical solutions given the prevailing understandings of health, risk and disease. However, current understandings of risk and disease are not simply the result of technological and scientific advances, they are also socially constructed. We interviewed members of the public, GPs and others, and found that rather than high cholesterol being seen as one of several risk factors that contributes to heart disease, it tended to be promoted simplistically to the status of a disease needing treatment of itself. Statins were justified by those taking them as different to 'unnecessary medicines'. However, some participants demonstrated resistance to statins, worried about over-medicalisation and deviated from accepted practices, indicating a complex 'muddling through' in the face of uncertainty
Asymptomatic · Disease · Medicalization · Pathology · Psychiatry · Public health · Qualitative research · Social science · Sociology · Healthcare cost, quality, practices · Medicine · Nursing · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare · Psychology · Surgery
Self and Others
Drugs for Life
Researcher–researched relationship in qualitative research
Selling sickness
Generating best evidence from qualitative research
The Converged Experience of Risk and Disease
Consolidated criteria for reporting qualitative research (Coreq)
Reimagining (Bio)Medicalization, Pharmaceuticals and Genetics
Current conditions or future risks
‘Prevention is better than cure, but …’
Foucault, Health and Medicine
Poststructural Policy Analysis
Gender and access to healthcare in the UK
Women and the new paradigm of health and medicine
The Discovery of Hyperkinesis
Biomedicalization
Sneaky disease
Coronary artery disease and the contours of pharmaceuticalization
Estimating the costs of medicalization
Recognizing medicalization and demedicalization
Problematizations in Health Policy
Medicine as an Institution of Social Control
How medicalization lost its way
Pharmaceuticalization of Society in Context
Medicalization and Social Control
Beyond beliefs
The pharmaceuticalisation of society? A framework for analysis
The rise of surveillance medicine
What is wrong with 'being a pill-taker'? The special case of statins
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,67 |
| Citation span | 2023 - 2025 (3) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 2 |